Biopharma’s 2025 M&A boom: Dealmaking surges as patent pressures intensify
Even with Johnson & Johnson’s (J&J) $14.6bn buyout of Intra-Cellular Therapies in January setting a strong deal-making tone, 2025 still…
Analysis
In a Honduran city, biotechs create gene therapy cocktails to fight aging
SCHOTT Pharma Sterile RTU Cartridge Production Facility, Lukacshaza, Hungary
Podcast: What key trends are people talking about in pharma?
Veeva Summit Europe: future-proofed AI set to bolster commercial pharma operations
Vetter Pharma Clinical Manufacturing Facility, Illinois, USA
New protein manufacturing technologies likely to play key role in “five to ten years”
FDA inspection reveals critical supply chain vulnerabilities
